Elodie Pronier

Elodie Pronier

UNVERIFIED PROFILE

Are you Elodie Pronier?   Register this Author

Register author
Elodie Pronier

Elodie Pronier

Publications by authors named "Elodie Pronier"

Are you Elodie Pronier?   Register this Author

14Publications

656Reads

28Profile Views

Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis.

Clin Cancer Res 2019 05 17;25(10):2956-2962. Epub 2019 Jan 17.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-3777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522317PMC
May 2019

Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity.

Cancer Cell 2018 01 21;33(1):44-59.e8. Epub 2017 Dec 21.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108173051
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2017.11.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760367PMC
January 2018

IDH1/2 mutations and BCL-2 dependence: an unexpected Chink in AML's armour.

Cancer Cell 2015 Mar;27(3):323-5

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2015.02.013DOI Listing
March 2015

Role of TET2 mutations in myeloproliferative neoplasms.

Curr Hematol Malig Rep 2012 Mar;7(1):57-64

Institut National de la Santé et de la Recherche Médicale, UMR 1009, Institut Gustave Roussy, Université Paris Sud (Paris 11), Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-011-0108-8DOI Listing
March 2012